TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/16/25 08:27 | 6/12/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 3 | 6 | P | 248 | 0.5328 | 0 | 466 | 7 | 7,155 | D | ||||||||||||||
6/13/25 13:05 | 6/11/25 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 2 | 2 | M.d | 23 | 5.14 | 0 | 5 | 5 | D | |||||||||||||||
6/11/25 16:33 | 6/9/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 5 | 6 | S.d | -7,469 | 75.90 | 0 | -98 | 904 | D | |||||||||||||||
6/6/25 16:05 | 6/4/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 7 | 13 | M.d | 0 | 0.00 | 0 | 71 | 16 | 503 | D | ||||||||||||||
6/3/25 17:00 | 6/1/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 5 | 9 | M.d | 3,058 | 245.83 | 0 | 12 | 89 | 26 | D | ||||||||||||||
5/12/25 14:30 | 5/12/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | 11 | 14 | P.d | 813 | 5.07 | 0 | 161 | 34 | 634 | D | ||||||||||||||
5/1/25 16:24 | 4/29/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | S | -2 | 8.50 | 0 | 0 | 19 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |